Serum beta 2 microglobulin and C-reactive protein in the monitoring of lymphomas: findings in a multicenter study and experience in selected patients.
D000328:Adult; D000368:Aged; D000970:Antineoplastic Agents / Q000627:therapeutic use; D001609:Beta-Globulins / Q000032:analysis*; D001799:Blood Sedimentation; D002097:C-Reactive Protein / Q000032:analysis*; D005260:Female; D006689:Hodgkin Disease / Q000097:blood* / Q000628:therapy; D006801:Humans; D008223:Lymphoma / Q000097:blood* / Q000628:therapy; D016403:Lymphoma, Large B-Cell, Diffuse / Q000097:blood; D008228:Lymphoma, Non-Hodgkin / Q000097:blood; D008297:Male; D008875:Middle Aged; D013997:Time Factors; D001613:beta 2-Microglobulin / Q000032:analysis*
D000970:Antineoplastic Agents; D001609:Beta-Globulins; D001613:beta 2-Microglobulin; D002097:C-Reactive Protein